Literature DB >> 6159297

Lectin staining of carbohydrates of haemic cells. II. The cells of normal lymphoid origin, of lymphatic leukaemias and related diseases.

W Jacobson, R W Stoddart, R D Collins.   

Abstract

Normal and leukaemic lymphoid cells, both human and murine, were stained for specific carbohydrates with three fluorescein-labelled lectins: Aprotinin for sialyl (or uronyl) groups: Ricinus agglutinin for galactosyl groups; and Concanavalin A for mannosyl (or glucosyl) groups. The method gives permanent preparations of sections from methanol fixed, paraffin embedded tissues, from blood and bone marrow films or touch preparations of lymph nodes that were methanol fixed. Whereas normal lymphocytes and lymphoblasts reacted strongly for sialyl groups, lymphoblasts of acute lymphoblastic leukaemia and lymphocytes of chronic lymphocytic leukaemia gave a much weaker reaction. The same was the case of the lymphocytes of the Sézary variant and the lymphocytes of macroglobulinaemia. The fine processes of the cells of hairy cell leukaemia stained well for sialyl groups. No obvious differences were detected between normal monocytes and the cells of monocytic leukaemia, nor between normal plasma cells and those of myeloma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159297     DOI: 10.1111/j.1365-2559.1980.tb02944.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

1.  Lectin receptors as markers of lymphoid cells. I. Demonstration in tissue section by peroxidase technique.

Authors:  J A Strauchen
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

2.  Binding of fluorescein isothiocyanate conjugated lectins to rat spermatogenic cells in tissue sections. Enhancement of lectin fluorescence obtained by fixation in Bouin's fluid.

Authors:  K O Söderström; R Malmi; K Karjalainen
Journal:  Histochemistry       Date:  1984

3.  Studies of lectin binding to normal and neoplastic lymphoid tissues. I. Normal nodes and Hodgkin's disease.

Authors:  V H Bramwell; D Crowther; J Gallagher; R W Stoddart
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.